(Total Views: 52)
Posted On: 02/22/2025 2:54:30 PM
Post# of 104396
KRTL Xstocklpicker88 @xstocklpicker88
·
Hello. I know you took my advice and bought some $KRTL. In Friday's bloodbath it hit another 52 week high closing at .133. This stock is rumored to be issuing a "monumental" news release that could actually move me and my traders to up our 12 month projection of 8.00 because we believe the acquisition they hinted at in their tweet is positioning Bolivia through $KRTL/ Sigma to expand their lower priced, substantial API compound supply chain into the US market immediately both undercutting China and India to substantially capture market share of the no longer allow Chinese to denominate and control the pricing and access of the Americans to their medicines.
As an American company their speculated merger with partner Bolivian based Sigma Corp. will allow $KRTL to use FDA registered subsidiary KRTL Biotech to immediately enter the US market with their registered FDA approval. 12 months may turn into 6 as Sigma is massive internationally and in Bolivia and resources plentiful and cheaper to produce with a diverse API supply chain of 6000 compounds. $KRTL will become a instant force, increasing supply available and bringing down drug costs for Americans. Thus will be timely and welcomed. $KRTL with the current anti China/anti big Pharma, Trump political backdrop is in facorr.
The exciting well timed and conceptualized America first business model solves the pricing and reliance of people's needed medicines responsible to saving lives of Americans should not leave American's vulnerable to CCP control of American's most needed lifeline. Our original 12 month 8.00 thesis has now been increased to 10.00 in 6 months as Sigma Corp is already one of the biggest suppliers of drugs in Bolivia and South America and a #NASDAQ listing for $KRTL is easily done using Sigma's assets and revenue's to qualify.
Anticipated resulting Institutional interest including Bolivian money will increase liquidity. Managements proven history of no dilution and absolute stated hatred for convertible debt makes me believe a massive appetite by smart money up listing on a National exchange will leave a small supply to be chased urgently making the percentage gain a once in a lifetime opportunity to spot on the #OTC early imo.
I believe the well established business with an immediate fast growing market share in short order values this opportunity to create a paradigm shift forever in Pharma to a non reliant Chinese controlled market. This perfectly executed business model that lessens China's pricing power permanently will receive immediate support of #MAGA politics towards the Chinese threat when dominating essential resources like our drug industry (A national security concern) as their committed to squeeze China out of US commerce 100%.
·
Hello. I know you took my advice and bought some $KRTL. In Friday's bloodbath it hit another 52 week high closing at .133. This stock is rumored to be issuing a "monumental" news release that could actually move me and my traders to up our 12 month projection of 8.00 because we believe the acquisition they hinted at in their tweet is positioning Bolivia through $KRTL/ Sigma to expand their lower priced, substantial API compound supply chain into the US market immediately both undercutting China and India to substantially capture market share of the no longer allow Chinese to denominate and control the pricing and access of the Americans to their medicines.
As an American company their speculated merger with partner Bolivian based Sigma Corp. will allow $KRTL to use FDA registered subsidiary KRTL Biotech to immediately enter the US market with their registered FDA approval. 12 months may turn into 6 as Sigma is massive internationally and in Bolivia and resources plentiful and cheaper to produce with a diverse API supply chain of 6000 compounds. $KRTL will become a instant force, increasing supply available and bringing down drug costs for Americans. Thus will be timely and welcomed. $KRTL with the current anti China/anti big Pharma, Trump political backdrop is in facorr.
The exciting well timed and conceptualized America first business model solves the pricing and reliance of people's needed medicines responsible to saving lives of Americans should not leave American's vulnerable to CCP control of American's most needed lifeline. Our original 12 month 8.00 thesis has now been increased to 10.00 in 6 months as Sigma Corp is already one of the biggest suppliers of drugs in Bolivia and South America and a #NASDAQ listing for $KRTL is easily done using Sigma's assets and revenue's to qualify.
Anticipated resulting Institutional interest including Bolivian money will increase liquidity. Managements proven history of no dilution and absolute stated hatred for convertible debt makes me believe a massive appetite by smart money up listing on a National exchange will leave a small supply to be chased urgently making the percentage gain a once in a lifetime opportunity to spot on the #OTC early imo.
I believe the well established business with an immediate fast growing market share in short order values this opportunity to create a paradigm shift forever in Pharma to a non reliant Chinese controlled market. This perfectly executed business model that lessens China's pricing power permanently will receive immediate support of #MAGA politics towards the Chinese threat when dominating essential resources like our drug industry (A national security concern) as their committed to squeeze China out of US commerce 100%.
(0)
(0)Scroll down for more posts ▼
